Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder

Psychiatric Genetics

Volumn 24, Issue 4, 2014, Pages 181-182

  Graham, David P ^a,b,c   Nielsen, David A ^a,b   Kosten, Thomas R ^a,b   Davis, Lori L ^d,e   Hamner, Mark B ^f   Makotkine, Iouri ^d,g   Yehuda, Rachel ^d,g  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL SULFATE; DISULFIRAM; DOPAMINE BETA MONOOXYGENASE; NEPICASTAT; NORADRENALIN; IMIDAZOLE DERIVATIVE; THIOKETONE;

CLINICAL PHARMACOLOGY; COMORBIDITY; DEMOGRAPHY; DRUG EFFICACY; ENZYME ACTIVITY; ETHNICITY; EVIDENCE BASED PRACTICE; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; INTERMETHOD COMPARISON; LETTER; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; ENZYMOLOGY; GENETICS; METABOLISM; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STRESS DISORDERS, POST-TRAUMATIC;

CLINICAL TRIALS AS TOPIC; DOPAMINE BETA-HYDROXYLASE; GENOTYPE; HUMANS; IMIDAZOLES; NOREPINEPHRINE; PILOT PROJECTS; STRESS DISORDERS, POST-TRAUMATIC; THIONES;

EID: 84903758030     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0000000000000039     Document Type: Letter

References (5)

1. Filser JG Spira J Fischer M Gattaz WF Müller WE 1988). The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients J Psychiatr Res 22 171-181.
2. Ipser JC Stein DJ (2012). Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol 15:825-840.
3. Mustapí M Pivac N Kozarí-Kovací D Dezeljin M Cubells JF Mück-Seler D (2007). Dopamine beta-hydroxylase (DBH ) activity and-1021C/T polymorphism of DBH gene in combat-related post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet 144B:1087-1089. (Pubitemid 350207786)
4. Stanley WC Li B Bonhaus DW Johnson LG Lee K Porter S et al. (1997). Catecholamine modulatory effects of nepicastat (RS-25560-197) a novel potent and selective inhibitor of dopamine-beta-hydroxylase. Br J Pharmacol 121:1803-1809. (Pubitemid 27343414)
5. Steenkamp MM Litz BT (2013). Psychotherapy for military-related posttraumatic stress disorder: review of the evidence. Clin Psychol Rev 33:45-53.